Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | NAUT | AVIR | ||
| Company | Urogen Pharma Ltd | Nautilus Biotechnology Inc | Atea Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.50 | 2.78 | 3.89 | ||
| High | 14.70 | 2.82 | 3.96 | ||
| Low | 14.14 | 2.64 | 3.80 | ||
| Last | 14.30 | 2.69 | 3.96 | ||
| Change | +0.04 | +0.02 | +0.13 | ||
| % Change | +0.28% | +0.75% | +3.39% | ||
| Volume | 164,400 | 65,300 | 164,700 | ||
| 20-Day Average Volume | 299,500 | 67,795 | 209,685 | ||
| Previous Close | 14.26 | 2.67 | 3.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.08 | 2.53 | 3.76 | ||
| 20-Day Raw Stochastic | 61.66% | 55.07% | 100.00% | ||
| 20-Day Relative Strength | 47.25% | 52.15% | 55.39% | ||
| Weighted Alpha | -35.00 | +1.55 | +16.85 | ||
| Today's Opinion | 40% Sell | 64% Sell | 64% Buy | ||
| Previous Opinion | 40% Sell | 64% Sell | 48% Buy | ||
| Last Month's Opinion | 8% Sell | 96% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.06% since 04/26/24 | +8.03% since 04/26/24 | +6.74% since 04/26/24 | ||
| Low | 13.78 on 04/30/24 | 2.47 on 04/30/24 | 3.69 on 04/30/24 | ||
| High | 14.70 on 05/03/24 | 3.00 on 04/30/24 | 3.96 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +4.69% since 04/03/24 | -2.89% since 04/03/24 | +1.54% since 04/03/24 | ||
| Low | 12.37 on 04/11/24 | 2.31 on 04/19/24 | 3.65 on 04/26/24 | ||
| High | 15.50 on 04/15/24 | 3.00 on 04/30/24 | 4.01 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | -13.18% since 02/02/24 | -0.37% since 02/02/24 | -3.88% since 02/02/24 | ||
| Low | 12.37 on 04/11/24 | 2.31 on 04/19/24 | 3.65 on 04/26/24 | ||
| High | 19.87 on 02/16/24 | 3.10 on 02/15/24 | 4.60 on 02/29/24 | ||
| 6-Month | |||||
| %Chg | +23.60% since 11/03/23 | -6.27% since 11/03/23 | +21.10% since 11/03/23 | ||
| Low | 10.92 on 11/15/23 | 2.31 on 04/19/24 | 2.77 on 11/22/23 | ||
| High | 19.87 on 02/16/24 | 3.45 on 12/27/23 | 4.60 on 02/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 335,392 | 336,963 | 333,523 | ||
| Shares Outstanding, K | 23,454 | 125,265 | 84,223 | ||
| Annual Sales | 82,710,000 | 0 | 0 | ||
| Annual Net Income | -102,240,000 | -63,680,000 | -135,960,000 | ||
| Last Quarter Sales | 23,530,000 | 0 | 0 | ||
| Last Quarter Net Income | -26,020,000 | -17,020,000 | -39,160,000 | ||
| 60-Month Beta | 1.09 | 1.22 | 0.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/14/24 | -0.15 on 04/30/24 | -0.47 on 02/28/24 | ||
| Latest Earnings Date | 05/09/24 | 04/30/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||